Short communication · 31 Mar 2021
Short communicationPublished 21 Jun 2022
Current Perspectives in ABO-Incompatible Kidney Transplant
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For a long time, ABO-incompatible living donor kidney transplantation has been considered contraindicated, due to the presence of isohemagglutinins, natural antibodies reacting with non-self ABO antigens. However, as the demand for kidney transplantation is constantly growing, methods to expand the donor pool have become increasingly important. Thus, in the last decades, specific desensitization strategies for ABOi transplantation have been developed. Nowadays, these regimens consist of transient removal of preformed anti-A or anti-B antibodies by using plasmapheresis or immunoadsorption and B-cell immunity modulation by CD20+ cells depletion with rituximab, in association with maintenance immunosuppression including corticosteroids, tacrolimus and mycophenolate mofetil. The outcome in ABO kidney transplantation have markedly improved over the years. In fact, although randomized trials are still lacking, recent meta-analysis has revealed that there is no difference in terms of graft and patient’s survival between ABOi and ABO compatible kidney transplant, even in the long term. However, many concerns still exist, because ABOi kidney transplantation is associated with an increased risk of bleeding and infectious complications, partly related to the effects of extracorporeal treatments and the strong immunosuppression. Thus, a continuous improvement in desensitization strategies, with the aim of minimize the immunosuppressive burden, on the basis of immune pathogenesis, antibodies titers and/or ABO blood group, is warranted. In this review, we discuss the main immune mechanisms involved in ABOi kidney transplantation, the pathogenesis of tolerance and the desensitization regimens, including immunoadsorption and plasmapheresis and the immunosuppressive protocol. Finally, we provide an overview of the outcome and future perspectives on ABOi kidney transplants.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 25 Jul 2020
ABO-Incompatible kidney transplantation: Current trends and future perspectives- Eleni Theodoropoulou, Tzaneio Prefecture General Hospital of Piraeus
Conference abstract · 28 May 2019
ABO-Incompatible kidney transplantation: Current trends and future perspectives
Conference abstract · 1 Apr 2016
ABO-Incompatible living donor kidney transplantation - The stockholm experience
Research article · 25 Sep 2023
Clinical Evidence of Immunoadsorption Column for Desensitization in ABO-incompatible Renal Transplantation (ABOi-RTx) Patients: A Case Series
More from this journal
The newest in Journal of Nephrology and Urology.
Research article · 7 Apr 2023
Diagnostic Value of PSMA PET Scan in Predicting Lymph Node Positivity in Patients with Prostate Cancer
Research article · 10 Jan 2023
Clinical and Urine Scoring in Assessing Long-Term Outcome of Acute Kidney Injury/Acute Kidney Disease (AKI/AKD) with Risk of Progression to Chronic Kidney Disease (CKD)
Short communication · 30 Aug 2022
Prognostic Factors of Renal Impairment in Multiple Myeloma in a Senegal
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology and Urology
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Gaetano La Manna”

